In 2044, three years after the Guanghan Reproductive Health Programme’s founding, the Joint Off-World Bioethics Council — convened under UNOLA Civil Health Office authority at the request of Guanghan and Zvezda chaplaincy and ethics representatives — issued a statement establishing an alternative pathway for individuals who declined partial ectogenesis on religious or personal grounds.
The Problem
By the Programme’s own reporting, approximately one in six eligible cases had declined the ectogenesis procedure, citing objections ranging from specific doctrinal positions on the moral status of extracorporeal gestation to more general discomfort with the procedure. The Council’s finding: a system offering only one risk-mitigation pathway was not adequately serving the founding charter’s absolute informed-consent requirement.
The Testimony
The Council heard testimony from chaplaincy and ethics representatives across Catholic, Sunni and Shi’a Islamic, Eastern Orthodox, and Orthodox Jewish traditions, alongside secular bioethicists and Programme medical staff. Despite widely differing doctrinal starting points — concerns ranged from the moral status of gestation occurring outside the body, to questions of lineage and parentage, to general precautionary objections — the practical request from every tradition converged on the same outcome: a safe pathway to full natural gestation, not a mandate to restrict ectogenesis for those who chose it.
The Council stated plainly: no tradition represented in these proceedings requested the Programme’s ectogenesis track be restricted, discontinued, or discouraged for those who consented to it.
The Sanctuary Protocol
Programme medical staff, in consultation with Svarog programme radiation-medicine specialists, confirmed that the dose-mapping work underlying the ectogenesis pathway’s risk model could support a second pathway: intensive habitat shielding for the duration of the identified high-risk gestational window, combined with a gestational-dosing variant of the Svarog compound class adapted specifically for use during pregnancy. This approach managed risk through shielding and pharmacological support rather than through removing the fetus from the body.
The Council directed that this pathway carry full disclosure of its modestly higher residual risk profile relative to ectogenesis. Programme staff were to be trained in presenting both pathways neutrally, without steering. The choice belonged to the individual carrying the pregnancy, “informed by whatever combination of medical, doctrinal, and personal reasoning they bring to it.”
The closing note: “A person facing pregnancy under conditions no one chose should not be made to choose, additionally, between their care and their conscience. The Sanctuary Protocol exists so that they do not have to.”